NeuroPace, Inc.
NPCE
$15.96
$0.332.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -145.11% | 21.94% | 59.59% | -31.29% | -25.50% |
| Total Depreciation and Amortization | -1.72% | 7.19% | 2.10% | 3.25% | 2.44% |
| Total Amortization of Deferred Charges | 7.94% | -10.00% | 27.27% | 12.24% | 0.00% |
| Total Other Non-Cash Items | -4.31% | 1.76% | -32.34% | 32.79% | 0.41% |
| Change in Net Operating Assets | -3,690.48% | 96.23% | -179.84% | 147.88% | -45.60% |
| Cash from Operations | -1,266.01% | 126.03% | 6.81% | 72.12% | -55.97% |
| Capital Expenditure | -20.62% | -223.33% | 82.14% | -354.05% | 5.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -20.62% | -223.33% | 82.14% | -354.05% | -101.89% |
| Total Debt Issued | -- | 100.00% | -100.23% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -98.62% | -- | -- | -99.71% | 7,440.64% |
| Repurchase of Common Stock | -100.00% | 13.73% | 41.38% | 99.65% | -54,002.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -126.14% | 370.21% | 87.68% | -109.04% | 2,389.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -692.24% | 147.26% | 46.92% | -130.63% | 783.55% |